Dimensional Fund Advisors’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Dimensional Fund Advisors’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.21M	Sell	112,492 -14,800	-12%	-$168K	﹤0.01%	2840
2022 Q2	$1.53M	Buy	127,292 +20,610	+19%	+$332K	﹤0.01%	2821
2022 Q1	$2.29M	Buy	106,682 +40,031	+60%	+$1.06M	﹤0.01%	2790
2021 Q4	$2.24M	Buy	66,651 +22,543	+51%	+$628K	﹤0.01%	2818
2021 Q3	$1.14M	Buy	44,108 +22,346	+103%	+$399K	﹤0.01%	3020
2021 Q2	$301K	Sell	21,762 -69	-0.3%	-$853	﹤0.01%	3256
2021 Q1	$232K	Buy	21,831 +2,253	+12%	+$25.7K	﹤0.01%	3266
2020 Q4	$158K	Hold	19,578	–	–	﹤0.01%	3250
2020 Q3	$146K	Buy	19,578 +5,644	+41%	+$50.1K	﹤0.01%	3235
2020 Q2	$125K	Hold	13,934	–	–	﹤0.01%	3257
2020 Q1	$133K	Buy	+13,934	New	+$167K	﹤0.01%	3247

Other funds holding OPNT

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ACA

Apis Capital Advisors New York $1.03B AUM 383.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Dimensional Fund Advisors's OPNT Position: Q3 2022 in Review

Dimensional Fund Advisors reduced its Opiant Pharmaceuticals, Inc. Common Stock (OPNT) stake by 12% in Q3 2022, selling an estimated $168K and leaving 112,492 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2840.

Dimensional Fund Advisors first reported a position in OPNT in Q1 2020 and has held it in 11 quarters since. The position peaked at $2.29M in Q1 2022. 32 funds tracked by Wall St. Rank hold OPNT as of Q3 2022.

Dimensional Fund Advisors held 112,492 shares of Opiant Pharmaceuticals, Inc. Common Stock worth $1.21M as of Q3 2022.
Dimensional Fund Advisors sold 14,800 Opiant Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $168K.
Opiant Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #2840 holding.
Dimensional Fund Advisors first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2020 and has held it in 11 quarters since.
Dimensional Fund Advisors's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $2.29M in Q1 2022.
32 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.